Skip to main content
Fig. 6 | Human Genomics

Fig. 6

From: SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects

Fig. 6

SCPx protein levels in WESP cells in response to fenofibrate and 4-hydroxytamoxifen treatment. A Western blot analyses of samples treated with various concentrations of fenofibrate for 24 h (left) and quantification of the blots (right). B Western blot analyses of samples treated with various concentrations of 4-hydroxytamoxifen (4-OHT) for 24 h (left) and quantification of the blots (right). C Western blot analyses of samples treated with 25 µM fenofibrate, 0.5 µM 4-OHT, and the fenofibrate + 4-OHT combination for 24 h (left) and the quantification of the blots (right). All Western blots were conducted in triplicate. Quantification was done using ImageJ analyses after normalizing to the untreated band for each group followed by normalizing to GAPDH. Data are shown as mean ± SEM (n = 3). *p < 0.05; **p < 0.01

Back to article page